Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis.
By Christina Wacker, Anna Prkno, F. Brunkhorst, P. Schlattmann. Lancet. Infectious Diseases (Print), 2013
1,096 citations recorded by the source corpus.
Subfields: Critical Care and Intensive Care Medicine, Epidemiology, Public Health, Environmental and Occupational Health
View Paper: https://www.semanticscholar.org/paper/75e5c8f7b85b3faa85ab5a5e650f51d54a3324bb
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Critical Care and Intensive Care Medicine
In Epidemiology
- P. Ginés
- M. Bernardi
- P. Angeli
- A. Rhodes
- G. Garcia‐Tsao
- Laura Evans
- Janice L. Zimmerman
- Mitchell M. Levy
Citations in the corpus
- Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 (2017, background): “antimicrobial therapy in severe infections and sepsis [211-216].”
- Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholecystitis (with videos) (2018, background): “(Level C) Although systematic reviews of the value of PCT for the diagnosis and severity grading of sepsis have been published [18, 19], a meta-analysis has found that inconsistencies in study design mean that it is not helpful in distinguishing between sepsis and non-sepsis [20].”
- Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013. (2014, background): “As far as the definition of the severity of the infection, elevated serum levels of PCT and CRP are correlated with the presence, course, and outcome of sepsis in patients with cirrhosis (Table 3A) [26] as in the general population [125].”